These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3524050)

  • 61. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.
    Treanor JJ; Kotloff K; Betts RF; Belshe R; Newman F; Iacuzio D; Wittes J; Bryant M
    Vaccine; 1999 Dec; 18(9-10):899-906. PubMed ID: 10580204
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
    Coelingh K; Olajide IR; MacDonald P; Yogev R
    Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Live cold-adapted influenza vaccine: state-of-the-art].
    Gendon IuZ
    Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
    Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children.
    Gruber WC; Kirschner K; Tollefson S; Thompson J; Reed G; Edwards KM; Wright PF
    J Infect Dis; 1993 Jul; 168(1):53-60. PubMed ID: 8390548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB; Gruber WC
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers.
    Mortiz AJ; Kunz C; Hofman H; Liehl E; Reeve P; Maassab HF
    J Infect Dis; 1980 Dec; 142(6):857-60. PubMed ID: 7462697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.
    Rudenko LG; Slepushkin AN; Monto AS; Kendal AP; Grigorieva EP; Burtseva EP; Rekstin AR; Beljaev AL; Bragina VE; Cox N
    J Infect Dis; 1993 Oct; 168(4):881-7. PubMed ID: 8376833
    [TBL] [Abstract][Full Text] [Related]  

  • 73. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Live influenza vaccine in the USSR: its development, study and practical use].
    Zhdanov VM; Aleksandrova GI; Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):3-13. PubMed ID: 3529762
    [No Abstract]   [Full Text] [Related]  

  • 75. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study.
    Koval TA; Aleksandrova GI; Grunis AM; Ivannikov YuG ; Medvedeva TE; Sychev SV; Shaposhnikova RP; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):194-200. PubMed ID: 395255
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains.
    Medvedeva TE; Lisovskaya KV; Polezhaev FI; Garmashova LM; Alexandrova GI; Ghendon YZ
    Acta Virol; 1984 May; 28(3):204-11. PubMed ID: 6147996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.